Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all‐cause admissions in patients on the liver transplant waiting list

BACKGROUND: Rifaximin reduces the risk of overt hepatic encephalopathy (HE) and is associated with significant reductions in hospitalisations and 30‐day readmissions. AIM: To examine the outcomes of patients listed for liver transplantation with a diagnosis of HE on rifaximin compared to those naïve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Aliment Pharmacol Ther
Main Authors: Salehi, Shayon, Tranah, Thomas H., Lim, Samuel, Heaton, Nigel, Heneghan, Michael, Aluvihare, Varuna, Patel, Vishal C., Shawcross, Debbie L.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Rifaximin for Prevention of Complications of Cirrhosis Pre‐transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6816014/
https://ncbi.nlm.nih.gov/pubmed/31169941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15326
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados